change language

FR UKR ES PT RU ZH

"SMART TEST 1.0"

The medical device for detect
the SARS-CoV-2(COVID-19) coronavirus
in the human body
LEARN MORE
SmartTest is a team of innovators, based in the United Kingdom and Ukraine. NEW projects in development: no-HEPA no-UV air purifiers, diagnostic devices for malaria, HIV and tuberculosis. Click here to learn more.

The “Smart Test 1.0” device has been certified

OPERATION MANUAL

“Smart Test 1.0” device is designed to detect the coronavirus SARS-CoV-2 (COVID-19) in the human body in a non-invasive way.

The device can be used by persons without medical education, aged 18 and above. The device can be used by these persons independently or with help of another person (an operator), who has familiarised themselves with Operation Manual.

Categorical medical contraindications to the use of “Smart Test 1.0” device for the diagnosed persons: use of a cardiac pacemaker and/or epilepsy.

ADVANTAGES OF THE NEW METHOD

Detection of asymptomatic patients in the early stages

The benefit of using the device is a short-term informative test for less than 1 minute. It does not require taking the patient's biomaterials.

Getting results in less than one minute

The ability to quickly and accurately test a large number of people in a short time. A full test on the “Smart Test 1.0” device takes less than one minute

Low cost of analysis

Significant savings on consumables for PCR diagnostics.

No more tears and makeup loss when taking nasal samples for PCR analysis

There is no need to take patient biomaterial

Environmental friendliness

It does not require recycling of human biological samples taken for analysis.

Let's save nature!

Easy to use

Using the device does not require any special knowledge for the user. The device can be used by persons without medical education, aged 18 and above.

The “Smart Test 1.0” device is designed to detect the coronavirus SARS-CoV-2(COVID-19) in the human body by analyzing the total electrical conductivity of the human body at different frequencies (non-invasive method) and belongs to the category of detectors and analyzers (detection and analysis apparatus). The device can be used in the premises of diagnostic and/or research and/or other institutions, enterprises and organizations, as well as in everyday life.

The device is connected to the user's computer with the "Windows" operating system (with a version not lower than Windows 10) via the included USB cable. 100V - 240V power supply is not required for the device!


DELIVERY SET:

  • “Smart Test 1.0” device - 1 pc.
  • Operation manual - 1 pc.
  • Flash drive with software "Smart Test 1.0" for PC - 1 pc.
  • License for the software "Smart Test 1.0" - 1 pc.
  • USB cable for connection to a PC - 1 pc.
  • Electrode connection cables - 1 pc.
  • Electrodes - 2 pcs.
The total weight - 1,5 kg.

The warranty period of operation is 12 months from the date of sale.

TO ORDER / INQUIRE

Areas of use of the device

  • Medical clinics and hospitals

    An effective and efficient method of rapid testing for your patients

  • Airports and train stations

    Rapid testing to detect infection in

    passenger flow

  • Shopping centers and movie theaters

    To ensure maximum security for visitors of your shopping center or movie theater

  • In educational institutions

    SARS-CoV-2 (COVID-19) COVID-19 testing for schools, universities and other educational institutions

  • Public receptions

    Express testing in large crowds, testing of company personnel

  • Stadiums, fitness centers

    A convenient solution for rapid testing for visitors of stadiums, fitness centers,

    swimming pools, etc.

Compliance with the requirements

  • Quality management system meets the requirements of the state standard DSTU ISO 9001

    The device is manufactured under license in accordance with Technical Specifications 26.6-2639012639-001:2021. Manufacturer of the device: Scientific and Production Association "International Medical Center" LLC (code 37219340), Kyiv city, Ukraine. Certificate quality management system (including the production of medical devices) No.UA230541 of December, 24 2021, issued by "Bureau Veritas Certification Ukraine"

  • Quality management system meets the requirements of the state standard DSTU ISO EN 13485

    Certificate quality management system No.80139.СУЯ.18-22 of October,3 2022, issued by Certification body "CERT ASU"
  • The device meets the requirements of the sanitary legislation
    According to the conclusions of the State sanitary and epidemiological expertise - Technical specifications TU U 26.6-2639012639-001:2021 ""Smart Test 1.0" device for detecting the SARS-CoV-2 (COVID-19) coronavirus in the human body" and "Smart Test 1.0" device are complies with the current sanitary legislation of Ukraine. Docs No. 12.2-18-2/1444, 01/27/2022 and No. 12.2-18-1/3719, 02/23/2022 
  • Quality management system meets the requirements of the Technical regulations on medical devices (Resolution of the Cabinet of Ministers of Ukraine №753 of October 2, 2013 "On approval of the Technical regulations on medical devices", appendix 3 (a. 8-11 are not includes))
    Certificate confirmation No. UA.TR.130.0890-22 of October,14 2022, issued by Certification body "CERT ASU". 
    Declaration No. UA.TR.130.0890/1-22 of October,14 2022
TO ORDER

We are looking for buyers of our startups that are ready for sale and investors for new projects

Four innovative startups

Startup 1: "Air purifier for residential premises of ships, boats and yachts"

Summary of our air purifier market: the main consumers are the merchant fleet, passenger liners and luxury yachts. According to the IACS, more than 40,000 vessels of various classes have been registered. The device has been created and tested. The device designed to purify the air supplied by the ship's ventilation and air conditioning system at a speed of not more than 2 m/s to cabins and other living and service spaces, and provides a high level of air purification from smoke, petroleum, formaldehyde, dust, odours, and high neutralization of viruses (coronaviruses), bacteria and fungi (moulds). Removes up to 99.98% of air pollutants with particle sizes more than 0,3 micron. It has a very low ozone release rate of 0.03 ppm. The device does not require replaceable HEPA filters and UV lamps. The device has a low power consumption (60W).
At present, the inventors of the air purifier for the residential premises of ships, boats and yachts are assembling a sample of a new purifier for HOME (OFFICE) USE. It is assumed that it has a calculated CADR value of 400 cubic meters/hour and can be used effectively in rooms with an air volume of 60-75 cubic meters (for example, 20-25 square meters and a ceiling height of 3 meters).
Startup 2: "Development of a new device for detect causative agents of tuberculosis and AIDS(HIV) in the human body in a non-invasive way".
Based on preliminary analysis, the market capacity of the device is estimated to be more than 4.3 billion euros. Project implementation period: 12 months from the start of funding.We already have: the conceptual approach in implementation, preliminary arrangements, device development and scientific team, directions of project expenses, approximate amount of payment under contracts to the project participants, preliminary calculation of profit.
Taking into account the need to complete the development, programming, organisation and conduct of pre- and clinical trials, the team of authors invites a potential investor to become a co-author of a new device and to buy 40% share in the startup for 2.0 million euros.
Startup 3: "Development of a new device for detect and treatment of malaria in the human body in a non-invasive way".
Based on preliminary analysis, the market capacity of the device is estimated to be more than 4.8 billion euros. Project implementation period: 12 months from the beginning of funding. We already have: the conceptual approach in implementation, preliminary arrangements, device development and scientific team, directions of project expenses, approximate amount of payment under contracts to the project participants, preliminary calculation of profit.Taking into account the need to complete the development, programming, organisation and conduct of pre- and clinical trials, the team of authors invites a potential investor to become a co-author of a new device and to buy 40% share in the startup for 2.33 million euros.

Startup 4: "The technology for detecting the SARS-CoV-2 (COVID-19) coronavirus in the human body in a non-invasive way"

The startup is ready for sale. The technology has been developed. According to a preliminary estimate, the market volume of the device is more than 4.3 billion euros. The medical device has been сertified. Obtained patent and copyright certificate for computer program for PC.

Learn more about technology
INQUIRE
© 2022-2024 Smart Test 1.0
All rights reserved. Own photo and from iStock
SMART TEST 1.0 DEVICE
FEEDBACK